Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siyuan Cui

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 11, 2025
[Research Progress on Immunosenescence in Elderly Patients 
with Advanced Non-small Cell Lung Cancer and Its Immunotherapy]Na Wang, Yaning Luo, Haoyu Lu, et al.
International Immunopharmacology|August 15, 2024
Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive reviewSiyuan Cui, Na Wang, Yangyueying Liang, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 2, 2019
The antagonist of CXCR1 and CXCR2 protects <i>db</i><i>/db</i> mice from metabolic diseases through modulating inflammationSiyuan Cui, Lu Qiao, Shanshan Yu, et al.
Cell Communication and Signaling : CCS|March 26, 2024
Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney diseaseSiyuan Cui, Xin Chen, Jiayu Li, et al.
Molecules (Basel, Switzerland)|September 23, 2022
The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for CrotonosideChenchen Ma, Peng Liu, Siyuan Cui, et al.
Medicine|June 30, 2021
Efficacy and safety of dapagliflozin in the treatment of chronic heart failure: A protocol for systematic review and meta-analysisXueyan Dong, Lili Ren, Yueli Liu, et al.
Mediators of Inflammation|May 29, 2018
Selenoprotein S Attenuates Tumor Necrosis Factor-<i>α</i>-Induced Dysfunction in Endothelial CellsSiyuan Cui, Lili Men, Yu Li, et al.
Current Cancer Drug Targets|October 15, 2025
Advances in Immune Checkpoint Inhibitors for the Treatment of Non-Small-Cell Lung Cancer with Central Nervous System Metastases: A ReviewYuan Meng, Lihan Shang, Jie Yang, et al.
Frontiers in Pharmacology|December 12, 2022
<i>Apol9a</i> regulates myogenic differentiation <i>via</i> the ERK1/2 pathway in C2C12 cellsXuan Jiang, Siyu Ji, Siyuan Cui, et al.
Frontiers in Oncology|March 18, 2026
Case Report: Clonal evolution of diffuse large B-cell lymphoma to plasmablastic lymphoma: diagnostic challenges in a case of gastric lesion with EBV-negative PBLJie Xu, Yueli Liu, Xi Feng, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 11, 2025
[Research Progress on Immunosenescence in Elderly Patients 
with Advanced Non-small Cell Lung Cancer and Its Immunotherapy]Na Wang, Yaning Luo, Haoyu Lu, et al.
International Immunopharmacology|August 15, 2024
Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive reviewSiyuan Cui, Na Wang, Yangyueying Liang, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 2, 2019
The antagonist of CXCR1 and CXCR2 protects <i>db</i><i>/db</i> mice from metabolic diseases through modulating inflammationSiyuan Cui, Lu Qiao, Shanshan Yu, et al.
Cell Communication and Signaling : CCS|March 26, 2024
Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney diseaseSiyuan Cui, Xin Chen, Jiayu Li, et al.
Molecules (Basel, Switzerland)|September 23, 2022
The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for CrotonosideChenchen Ma, Peng Liu, Siyuan Cui, et al.
Medicine|June 30, 2021
Efficacy and safety of dapagliflozin in the treatment of chronic heart failure: A protocol for systematic review and meta-analysisXueyan Dong, Lili Ren, Yueli Liu, et al.
Mediators of Inflammation|May 29, 2018
Selenoprotein S Attenuates Tumor Necrosis Factor-<i>α</i>-Induced Dysfunction in Endothelial CellsSiyuan Cui, Lili Men, Yu Li, et al.
Current Cancer Drug Targets|October 15, 2025
Advances in Immune Checkpoint Inhibitors for the Treatment of Non-Small-Cell Lung Cancer with Central Nervous System Metastases: A ReviewYuan Meng, Lihan Shang, Jie Yang, et al.
Frontiers in Pharmacology|December 12, 2022
<i>Apol9a</i> regulates myogenic differentiation <i>via</i> the ERK1/2 pathway in C2C12 cellsXuan Jiang, Siyu Ji, Siyuan Cui, et al.
Frontiers in Oncology|March 18, 2026
Case Report: Clonal evolution of diffuse large B-cell lymphoma to plasmablastic lymphoma: diagnostic challenges in a case of gastric lesion with EBV-negative PBLJie Xu, Yueli Liu, Xi Feng, et al.
Pageof 7